Ownership history in NATIXIS · 23 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 70,978 | +56,923 | +405.0% | 0.09% | $19.4M | $272.45 |
| 2024 Q1 | REDUCED | 14,055 | -2,937 | -17.3% | 0.01% | $2.8M | $194.51 |
| 2023 Q4 | REDUCED | 16,992 | -201,882 | -92.2% | 0.02% | $2.9M | $168.53 |
| 2023 Q3 | ADDED | 218,874 | +217,951 | +23613.3% | 0.25% | $32.4M | $144.41 |
As of 2025 Q4 — sorted by position size